TSS
ABUS icon

Two Sigma Securities’s Arbutus Biopharma ABUS Stock Holding History

Two Sigma Securities’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+23,470
New +$103K 0.01% 1283
2025
Q4 		– Sell
-11,534
Closed -$52.4K – 1427
2025
Q3 		$52.4K Sell
11,534
-5,251
-31% -$19.3K 0.01% 982
2025
Q2 		$51.9K Buy
+16,785
New +$55.7K 0.01% 1110
2025
Q1 		– Sell
-19,475
Closed -$63.7K – 1403
2024
Q4 		$63.7K Buy
+19,475
New +$71.6K 0.01% 1159
2023
Q2 		– Sell
-21,235
Closed -$64.3K – 2724
2023
Q1 		$64.3K Buy
+21,235
New +$59.9K ﹤0.01% 2253
2018
Q1 		– Sell
-11,294
Closed -$57K – 2631
2017
Q4 		$57K Sell
11,294
-1,311
-10% -$7.68K ﹤0.01% 1510
2017
Q3 		$78K Buy
+12,605
New +$53.9K 0.01% 697

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Securities's ABUS Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 23,470 shares worth $113K. The stake represents 0.01% of the portfolio and ranks #1283 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in ABUS as recently as Q3 2025.

Two Sigma Securities first reported a position in ABUS in Q3 2017 and has held it in 7 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Two Sigma Securities held 23,470 shares of Arbutus Biopharma worth $113K as of Q2 2026.
  • Arbutus Biopharma was a new Two Sigma Securities position in Q2 2026.
  • Arbutus Biopharma made up 0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1283 holding.
  • Two Sigma Securities first reported a position in Arbutus Biopharma in Q3 2017 and has held it in 7 quarters since.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.